Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin and Naltrexone for Alcohol Craving
NCT05093296Phase 3Completed
- Sponsor
- Central Institute of Mental Health
- Start
- Dec 2021
- Primary completion
- Jul 2023
- Countries
- 1
01
Overview
A Phase 3 trial of oxytocin nasal spray in alcohol use disorder (AUD), sponsored by Central Institute of Mental Health. Started Dec 2021; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT05093296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05093296.